These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

96 related articles for article (PubMed ID: 310838)

  • 1. Characterization of a xenoantiserum produced against three molar KCl-solubilized antigens obtained from a non-T, non-B (pre-B) acute lymphoblastic leukemia cell line.
    LeBien TW; Hurwitz RL; Kersey JH
    J Immunol; 1979 Jan; 122(1):82-8. PubMed ID: 310838
    [No Abstract]   [Full Text] [Related]  

  • 2. Rabbit antiserum against a non-T, non-B leukemia cell line that carries the Ph1 chromosome (NALM-1): antibody specific to a non-T, non-B acute lymphoblastic leukemia antigen.
    Koshiba H; Minowada J; Pressman D
    J Natl Cancer Inst; 1978 Oct; 61(4):987-91. PubMed ID: 81309
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Characterization of xenoantiserum produced against B cell acute lymphoblastic leukemia cell line.
    Akagi T; Sonobe H; Miyoshi I; Yoshimoto S
    Acta Med Okayama; 1982 Oct; 36(5):325-30. PubMed ID: 6184955
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Human lymphocyte surface antigens. Part 1. Production and characterization of heteroantisera against cell lines derived from T-cell acute lymphoblastic leukemia and adult T-cell leukemia (author's transl)].
    Yoshimoto S
    Nihon Ketsueki Gakkai Zasshi; 1981 Nov; 44(6):1153-62. PubMed ID: 6977255
    [No Abstract]   [Full Text] [Related]  

  • 5. [Acute lymphoblastic leukemia in children. The use of antisera specific for lymphocyte populations in a classification trial].
    Andary M; Clot J; Brochier J; Levallois C; Dossa D; Marguerite G; Jean R
    Arch Fr Pediatr; 1979; 36(8):751-9. PubMed ID: 317241
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Strong, specific anti-human leukemia antisera prepared with the use of purified cell membrane antigen.
    Negoro S; Seon BK
    Cancer Res; 1981 Jul; 41(7):2973-6. PubMed ID: 6972802
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Markers of cellular differentiation in acute lymphoblastic leukemia.
    Peiper SC; Stass SA
    Arch Pathol Lab Med; 1982 Jan; 106(1):3-8. PubMed ID: 6976157
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Induction of several new antigens, including a T cell-associated antigen, following conversion of the EBV-negative B cell line RAMOS to EHRB-RAMOS by Epstein-Barr virus.
    Rosenthal KS; Shuman H; Strominger JL
    J Immunol; 1981 Aug; 127(2):746-54. PubMed ID: 6166685
    [No Abstract]   [Full Text] [Related]  

  • 9. The surface antigenicity of serially transplantable malignant human lymphoid cells derived from subjects with infectious mononucleosis, Hodgkin's disease, chronic lymphatic leukemia, or acute lymphoblastic leukemia.
    Galli SJ; Adams RA
    Cancer Res; 1974 Feb; 34(2):298-303. PubMed ID: 4589952
    [No Abstract]   [Full Text] [Related]  

  • 10. [Lymphoblastic leukemia and immunological markers].
    Ifrah N; Perrot JY; Marie JP; Boasson M; Zittoun R
    Ann Med Interne (Paris); 1987; 138(7):527-32. PubMed ID: 3326452
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Detection and partial characterization of human T and B lymphocyte membrane antigens with antisera to HSB and SB cell lines.
    Anderson JK; Metzgar RS
    J Immunol; 1978 Jan; 120(1):262-71. PubMed ID: 304868
    [No Abstract]   [Full Text] [Related]  

  • 12. The use of column-bound B lymphocytes for absorption of antisera to T lymphocyte antigens.
    Hudson L; Phillips B
    J Immunol; 1973 Jun; 110(6):1663-6. PubMed ID: 4123285
    [No Abstract]   [Full Text] [Related]  

  • 13. Identification, enumeration, and isolation of B and T lymphocytes from human peripheral blood. Report of a WHO-IARC-sponsored workshop on human B and T cells, London, 15-17 July 1974.
    Scand J Immunol; 1974; 3(5):521-32. PubMed ID: 4138857
    [No Abstract]   [Full Text] [Related]  

  • 14. Human T cell leukemia antigens on the cell membranes: purification molecular characterization, and preparation of specific antisera.
    Seon BK; Negoro S; Minowada J; Yoshizaki K
    J Immunol; 1981 Dec; 127(6):2580-8. PubMed ID: 6975329
    [No Abstract]   [Full Text] [Related]  

  • 15. Identification of a human endothelial cell antigen with monoclonal antibody 44G4 produced against a pre-B leukemic cell line.
    Gougos A; Letarte M
    J Immunol; 1988 Sep; 141(6):1925-33. PubMed ID: 3262644
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Immunity in leukemia.
    Gatti RA
    Boll Ist Sieroter Milan; 1974; 53(1):suppl:275-81. PubMed ID: 4277522
    [No Abstract]   [Full Text] [Related]  

  • 17. Reactivity of acute lymphoblastic leukemia and normal bone marrow cells with the monoclonal anti-B-lymphocyte antibody, anti-Y 29/55.
    Hirt A; Baumgartner C; Forster HK; Imbach P; Wagner HP
    Cancer Res; 1983 Sep; 43(9):4483-5. PubMed ID: 6603266
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The application of monoclonal antibodies to the characterization and diagnosis of lymphoid neoplasms: a review of recent studies.
    Knowles DM; Dodson LD; Raab R; Mittler RS; Talle MA; Goldstein G
    Diagn Immunol; 1983; 1(3):142-9. PubMed ID: 6333955
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Characterization of a subpopulation of human T lymphocytes reactive with an heteroantiserum to human brain.
    Brouet J; Toben H
    J Immunol; 1976 Apr; 116(4):1041-4. PubMed ID: 1082900
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Human leukemia antigen. I. Production and characterization of antisera.
    Billing R; Terasaki PI
    J Natl Cancer Inst; 1974 Dec; 53(6):1635-8. PubMed ID: 4612163
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 5.